IL21 and autoimmune disease: IL-21 and IL-6 together could induce CD4+CXCR+PD-1+ Tfh cell differentiation, and this Tfh cells could promote immunoglobulin production form B cells (Figure S1), thus Tfh cells could be a therapeutic target for treatment of autoimmune disease.